GRCE

Grace Therapeutics
GRCE

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $53.1K invested in Grace Therapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$14K
2
+$10K
3
+$641

Top Sellers

1
-$22K
2
-$17K
3
-$9.18K
4
TSS
Two Sigma Securities
New York
-$5.05K
5
SIAP
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$14K
2
$10K
3
$10K
4
$10K
5
$6K
6
$2K
7
$1K
8
$101
9
$3
10
–
11
–
12
–